Endometrial Regeneration in Asherman's Syndrome: Clinical and Translational evidence of Stem Cell Therapies
- PMID: 30760192
- DOI: 10.2174/1574888X14666190213100528
Endometrial Regeneration in Asherman's Syndrome: Clinical and Translational evidence of Stem Cell Therapies
Abstract
Asherman's Syndrome or Intrauterine adhesions is an acquired uterine condition where fibrous scarring forms within the uterine cavity, resulting in reduced menstrual flow, pelvic pain and infertility. Until recently, the molecular mechanisms leading to the formation of fibrosis were poorly understood, and the treatment of Asherman's syndrome has largely focused on hysteroscopic resection of adhesions, hormonal therapy, and physical barriers. Numerous studies have begun exploring the molecular mechanisms behind the fibrotic process underlying Asherman's Syndrome as well as the role of stem cells in the regeneration of the endometrium as a treatment modality. The present review offers a summary of available stem cell-based regeneration studies, as well as highlighting current gaps in research.
Keywords: Asherman's syndrome; Endometrium; human embryonic stem cells; intrauterine adhesions; scaffold; stem cells..
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Similar articles
-
Bone Marrow-Derived Stem Cell (BMDSC) transplantation improves fertility in a murine model of Asherman's syndrome.PLoS One. 2014 May 12;9(5):e96662. doi: 10.1371/journal.pone.0096662. eCollection 2014. PLoS One. 2014. PMID: 24819371 Free PMC article.
-
Autologous cell therapy with CD133+ bone marrow-derived stem cells for refractory Asherman's syndrome and endometrial atrophy: a pilot cohort study.Hum Reprod. 2016 May;31(5):1087-96. doi: 10.1093/humrep/dew042. Epub 2016 Mar 22. Hum Reprod. 2016. PMID: 27005892
-
Effect of Autologous Adipose-Derived Stromal Vascular Fraction Transplantation on Endometrial Regeneration in Patients of Asherman's Syndrome: a Pilot Study.Reprod Sci. 2020 Feb;27(2):561-568. doi: 10.1007/s43032-019-00055-y. Epub 2020 Jan 1. Reprod Sci. 2020. PMID: 32046396
-
Regenerating endometrium from stem/progenitor cells: is it abnormal in endometriosis, Asherman's syndrome and infertility?Curr Opin Obstet Gynecol. 2013 Jun;25(3):193-200. doi: 10.1097/GCO.0b013e32836024e7. Curr Opin Obstet Gynecol. 2013. PMID: 23562953 Review.
-
[Intrauterine adhesions--Asherman's syndrome].Duodecim. 2010;126(21):2486-91. Duodecim. 2010. PMID: 21171473 Review. Finnish.
Cited by
-
Transcriptomic profiling analysis of human endometrial stromal cells treated with autologous platelet-rich plasma.Reprod Med Biol. 2023 Jan 22;22(1):e12498. doi: 10.1002/rmb2.12498. eCollection 2023 Jan-Dec. Reprod Med Biol. 2023. PMID: 36704119 Free PMC article.
-
Human Platelet-Rich Plasma Facilitates Angiogenesis to Restore Impaired Uterine Environments with Asherman's Syndrome for Embryo Implantation and Following Pregnancy in Mice.Cells. 2022 May 5;11(9):1549. doi: 10.3390/cells11091549. Cells. 2022. PMID: 35563855 Free PMC article.
-
Human umbilical cord blood-derived MSCs trans-differentiate into endometrial cells and regulate Th17/Treg balance through NF-κB signaling in rabbit intrauterine adhesions endometrium.Stem Cell Res Ther. 2022 Jul 15;13(1):301. doi: 10.1186/s13287-022-02990-1. Stem Cell Res Ther. 2022. PMID: 35841027 Free PMC article.
-
Cell-based therapy in thin endometrium and Asherman syndrome.Stem Cell Res Ther. 2022 Jan 28;13(1):33. doi: 10.1186/s13287-021-02698-8. Stem Cell Res Ther. 2022. PMID: 35090547 Free PMC article. Review.
-
Recent developments in bio-scaffold materials as delivery strategies for therapeutics for endometrium regeneration.Mater Today Bio. 2021 Feb 25;11:100101. doi: 10.1016/j.mtbio.2021.100101. eCollection 2021 Jun. Mater Today Bio. 2021. PMID: 34036261 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources